학술논문
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials
Document Type
Article
Author
Source
In The Lancet Infectious Diseases May 2023 23(5):621-633
Subject
Language
ISSN
1473-3099